SCHEMBL27469837

SCHEMBL27469837

O=C(O)c1noc(-c2cccc(F)c2F)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.54
RAB9A P51151 10/20 0.54
HDAC6 Q9UBN7 3/20 0.51
MAOA P21397 1/20 0.51
BLVRB P30043 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.45
KMT2A Q03164 3/20 0.45
PKM P14618 2/20 0.45
MEN1 O00255 2/20 0.45
NFKB1 P19838 2/20 0.45
NFKB2 Q00653 2/20 0.45
RELA Q04206 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MAPK1 P28482 1/20 0.45
DHODH Q02127 2/20 0.42
HDAC1 Q13547 2/20 0.41
HDAC8 Q9BY41 1/20 0.41
GAA P10253 1/20 0.40
GRK6 P43250 1/20 0.39
KMO O15229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL60044 0.78 MAOA (0.83) NPC1RAB9AHDAC6MAOABLVRB
SCHEMBL14662787 0.76 CTSA (0.58)
SCHEMBL14662788 0.76 CTSA (0.58)
SCHEMBL387944 0.76 MAOA (0.58) NPC1RAB9AHDAC6MAOABLVRB
SCHEMBL31005040 0.76 NPC1 (0.47) NPC1RAB9AHDAC6MAOABLVRB
SCHEMBL892914 0.76 NPC1 (0.47) NPC1RAB9AHDAC6MAOABLVRB
SCHEMBL19814658 0.76 KMO (0.54) NPC1RAB9AHDAC6MAOABLVRB
SCHEMBL14662074 0.75 CTSA (0.59)
SCHEMBL14662071 0.75 CTSA (0.59)
SCHEMBL23268875 0.75 NPC1 (0.51) NPC1RAB9AHDAC6SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4618978-A1 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics Inc. (US) 2025-09-24 EP disclosed
WO-2024108147-A1 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-05-23 WO disclosed
WO-2024108147-A1 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-05-23 WO disclosed